Mimetis Biomaterials Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Mimetis Biomaterials General Information

Description

Designer and manufacturer of bone regenerative medical products intended for printing patient-specific biomimetic synthetic bone grafts in 3D and regenerating it physiologically. The company's product uses biomimicry as a differential technological basis and synthetically manufactures a bone graft for patient-specific indications that matches the features of a natural bone to provide solutions for complex cases, thereby enabling clients to facilitate the colonization of the graft by bone cells and avoid stacking over time.

Contact Information

Website
www.mimetis.com
Formerly Known As
Subtilis Biomaterials
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Carrer de Cartagena, 245
  • 3 Floor
  • 08025 Barcelona
  • Spain
+34 644
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Parent Company
Nobel Biocare Services
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • Carrer de Cartagena, 245
  • 3 Floor
  • 08025 Barcelona
  • Spain
+34 644

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mimetis Biomaterials Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 01-Sep-2022 Completed Clinical Trials - Phase 2
12. Later Stage VC (Series A) 19-May-2021 Completed Clinical Trials - Phase 2
11. Grant Completed Clinical Trials - Phase 2
10. Secondary Transaction - Private 30-Sep-2019 Completed Clinical Trials - Phase 2
9. Grant 01-Jan-2019 Completed Clinical Trials - Phase 2
8. Equity Crowdfunding 14-Nov-2018 Completed Clinical Trials - Phase 2
7. Grant 01-Jan-2018 Completed Startup
6. Grant 01-Jan-2016 Completed Startup
5. Grant $201K $1.15M Completed Startup
4. Early Stage VC 01-Jan-2016 $762K $1.15M Completed Startup
To view Mimetis Biomaterials’s complete valuation and funding history, request access »

Mimetis Biomaterials Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 4,978 $68.02 $68.02 1x $68.02 15.34%
To view Mimetis Biomaterials’s complete cap table history, request access »

Mimetis Biomaterials Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • Pending

  • Expiring in next 12 mo

Mimetis Biomaterials Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3787700-A1 Synthetic bone graft Active 03-May-2018
EP-3563881-A1 Synthetic bone graft Inactive 03-May-2018
EP-3787700-B1 Synthetic bone graft Active 03-May-2018
ES-2978589-T3 Synthetic bone graft Active 03-May-2018
EP-3787700-C0 Synthetic bone graft Active 03-May-2018 A61L27/12
To view Mimetis Biomaterials’s complete patent history, request access »

Mimetis Biomaterials Executive Team (6)

Name Title Board Seat
Ana Espinoza Chief Executive Officer and Commercial Director
Xavier Gil Ph.D Co-Founder
You’re viewing 2 of 6 executive team members. Get the full list »

Mimetis Biomaterials Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mimetis Biomaterials Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Barcelona Activa Accelerator/Incubator Minority
Biocat Accelerator/Incubator Minority
Caixa Capital Risc Venture Capital Minority
Centro para el Desarrollo Tecnologico Industrial Government
European Commission Government
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Mimetis Biomaterials FAQs

  • When was Mimetis Biomaterials founded?

    Mimetis Biomaterials was founded in 2013.

  • Who is the founder of Mimetis Biomaterials?

    Yassine Maazouz, David Pastorino, Xavier Gil Ph.D, and Maria-Pau Ginebra Ph.D are the founders of Mimetis Biomaterials.

  • Who is the CEO of Mimetis Biomaterials?

    Ana Espinoza is the CEO of Mimetis Biomaterials.

  • Where is Mimetis Biomaterials headquartered?

    Mimetis Biomaterials is headquartered in Barcelona, Spain.

  • What is the size of Mimetis Biomaterials?

    Mimetis Biomaterials has 8 total employees.

  • What industry is Mimetis Biomaterials in?

    Mimetis Biomaterials’s primary industry is Therapeutic Devices.

  • Is Mimetis Biomaterials a private or public company?

    Mimetis Biomaterials is a Private company.

  • What is Mimetis Biomaterials’s current revenue?

    The current revenue for Mimetis Biomaterials is .

  • How much funding has Mimetis Biomaterials raised over time?

    Mimetis Biomaterials has raised $1.38M.

  • Who are Mimetis Biomaterials’s investors?

    Barcelona Activa, Biocat, Caixa Capital Risc, Centro para el Desarrollo Tecnologico Industrial, and European Commission are 5 of 8 investors who have invested in Mimetis Biomaterials.

  • When was Mimetis Biomaterials acquired?

    Mimetis Biomaterials was acquired on 01-Sep-2022.

  • Who acquired Mimetis Biomaterials?

    Mimetis Biomaterials was acquired by Nobel Biocare Services.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »